While the number of FDA inspections of clinical investigators has grown in the last 30 years, the proportion of objectionable findings has dramatically decreased, says a new report. The number of clinical investigator inspections averaged 329 a year between 1997 and 2012 compared to an average of 235 a year between 1977 and 1996. That is due to an increase in the number of for-cause inspections in the U.S. and an increase in data-audit inspections in emerging market countries.
Drug Industry Daily